• Study on the Safety and Effects of Lutetium (177Lu) Vipivotide Tetraxetan in Adults with Metastatic Castration-Resistant Prostate Cancer

    Recruiting

    1 1 1 1
    Investigated diseases:
    Germany The Netherlands Spain
  • Study of Pegozafermin Treatment for Patients with Liver Cirrhosis due to Metabolic Dysfunction-Associated Steatohepatitis (MASH)

    Recruiting

    3 1
    Investigated diseases:
    Investigated drugs:
    Belgium Bulgaria France Germany Hungary Italy +3
  • Title: Long-term treatment study of oral decitabine and cedazuridine combination for patients with AML, MDS, CMML, or solid tumors who previously received ASTX727

    Recruiting

    2 1 1
    Investigated drugs:
    Austria Bulgaria Germany Hungary Poland Romania +2
  • Study on Colchicine for Reducing Heart Damage in Patients with Acute Myocarditis

    Recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    France
  • Study on the Effectiveness and Safety of Ademetionine Injections for Patients with Major Depressive Disorder Not Responding to Antidepressants

    Recruiting

    3 1 1
    Italy
  • Study of Monalizumab for Patients with Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Haploidentical Transplantation

    Recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    Italy
  • Study on the Safety of Inhaled Teicoplanin for Treating Staphylococcus aureus Infections in Cystic Fibrosis Patients

    Recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Italy
  • Safety Study of Almagate for Pregnant Women with Heartburn and Reflux, Assessing Effects on Mother and Baby

    Recruiting

    3 1 1 1
    Investigated drugs:
    Spain
  • Study on the Safety of CD19 CAR-T Cells, Cyclophosphamide, and Fludarabine in Adults with Refractory or Relapsed Acute Myeloid Leukemia Expressing CD19

    Recruiting

    1 1 1 1
    Investigated diseases:
    France
  • Study on Ruxolitinib and Methoxsalen for Patients with Steroid-Refractory Chronic Graft-versus-Host Disease

    Recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Austria Germany

powered by